BJPsych Bulletin, published by Cambridge University Press, stands as a vital resource in the field of Psychiatry and Mental Health, offering open access articles since 2015 to foster widespread dissemination of knowledge. With an ISSN of 2056-4694 and an E-ISSN of 2056-4708, this journal has established an impactful presence, ranking in the Q2 category for Psychiatry and Mental Health in 2023 and placing within the 59th percentile among its peers according to Scopus, which ranks it #229 out of 567 in the category. Covering a diverse range of topics from clinical practices to psychiatric research, the BJPsych Bulletin encourages contributions that explore innovative ideas and discussions around mental health. Its critical role in advancing research and practice in the discipline is complemented by its accessibility to researchers, professionals, and students globally, ensuring that cutting-edge findings reach a broad audience and support the continuous evolution of mental health sciences.

NERVENARZT, published by Springer, has established itself as a significant platform in the fields of Medicine, Neurology, and Psychiatry since its inception in 1947. With a focus on a wide array of topics in neurological and psychiatric health, the journal plays a crucial role in disseminating cutting-edge research and clinical insights that enhance understanding and treatment of neurological disorders. The journal is currently positioned in the Q3 category across various fields, reflecting its role in the academic community, and provides valuable contributions to both the clinical and theoretical aspects of neurology and psychiatry. While it does not offer open access options, NERVENARZT continues to make significant strides in literature with its comprehensive articles and research findings, aimed at researchers, healthcare professionals, and students interested in the latest developments in the neuroscience and mental health landscapes. Operating under rigorous academic standards, it holds respected rankings with Scopus, further underscoring its commitment to impactful scholarship through the years.

Canadian Journal of Psychiatry-Revue Canadienne de Psychiatrie, published by SAGE Publications Inc, has established itself as a leading voice in the field of psychiatry and mental health since its inception in 1979. With an impact factor that places it in the top quartile (Q1) of its category as of 2023, this journal ranks impressively at #112 out of 567 in the Scopus database, highlighting its significance and influence in the academic community. The journal provides a vital platform for disseminating cutting-edge research, innovative methodologies, and critical reviews, making it an essential resource for researchers, practitioners, and students alike. Although it currently does not offer open access, the journal's commitment to advancing the understanding of psychiatric disorders and mental health issues is unwavering. Situated in Canada, it serves both a national and international audience, fostering collaboration and knowledge sharing across disciplines. As the journal continues to evolve through 2024, it remains dedicated to enhancing the quality of mental health care and promoting the importance of psychiatric research.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE is a distinguished publication dedicated to advancing the understanding of psychiatric practice and mental health issues within a medical framework. Published by SAGE PUBLICATIONS INC, this journal has been a trusted source in the field since its inception, with its archives dating back to 1973. It offers a comprehensive exploration of psychiatric research, clinical studies, and theoretical advancements that seek to bridge the gap between psychiatry and general medicine. With an impact factor reflective of its quality and relevance, categorized in the Q3 quartile in Psychiatry and Mental Health, this journal stands as a vital resource for researchers, clinicians, and students alike. Although operating on a traditional subscription model, the extensive knowledge shared within its pages contributes significantly to ongoing discussions in psychiatric and mental health education and practice. As the field continually evolves, the INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE remains committed to fostering innovative and impactful scholarship that resonates with professionals navigating the complexities of mental health in clinical contexts.

Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.

The Journal of Psychiatric and Mental Health Nursing, published by WILEY, serves as a leading academic platform dedicated to advancing the fields of psychiatric and mental health nursing. With a commendable impact factor and a ranking of #13 out of 45 in the Scopus category of Nursing - Psychiatric Mental Health, this journal is a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of the complex interplay between mental health practices and nursing. Since its inception in 1994, the journal has consistently contributed high-quality, peer-reviewed articles that explore innovative practices, evidence-based research, and critical reviews in the burgeoning field of mental health. As it looks toward its converged years of 2024, the journal firmly positions itself in the Q2 quartile of Psychiatry and Mental Health, underscoring its commitment to disseminating impactful research that can inform clinical practice and shape future policies. Although the journal does not currently offer Open Access options, its reach and influence continue to make it an essential resource for those engaged in the vital fields of psychiatric and mental health nursing.

Australasian Psychiatry is a distinguished peer-reviewed journal published by SAGE Publications Ltd, focusing on the dynamic fields of Psychiatry and Mental Health. With a commendable Q3 ranking in the 2023 category quartiles, it serves as a vital resource for researchers, clinicians, and students alike, contributing to the understanding of mental health issues and advancements in psychiatric practice. Established in 1967, the journal has consistently disseminated original research, clinical reviews, and evidence-based practices, fostering a platform for discussing the contemporary challenges faced by mental health professionals. While operating from the heart of the United Kingdom, it aims to bridge regional insights with global trends, celebrating the diversity of thought in psychiatric discourse. Access to its rich content is through institutional subscriptions, ensuring that valuable research is within reach of dedicated scholars and mental health advocates. As the field evolves, Australasian Psychiatry remains committed to advancing knowledge and practice in mental health, positioning itself as an indispensable part of the academic landscape.

JOURNAL OF PSYCHIATRY & NEUROSCIENCE, published by the CMA-Canadian Medical Association, serves as a pivotal platform for disseminating cutting-edge research in the fields of psychiatry and neuroscience. This esteemed journal, indexed with the ISSN 1180-4882 and E-ISSN 1488-2434, focuses on advancing our understanding of mental health through meticulous peer-reviewed articles, reviews, and clinical studies. With an impressive impact within the research community, it has achieved notable rankings, including Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health, as well as Q2 in Biological Psychiatry as of 2023. The journal fosters critical dialogue among scholars and practitioners by offering insights into the complexities of brain function and mental disorders, making it a fundamental resource for healthcare professionals, researchers, and students alike. Although it operates under a subscription model, its rich content continues to inform and influence the advancement of mental health science, affirming its role in bridging the gap between research and clinical practice.

ACTA PSYCHIATRICA SCANDINAVICA is a leading journal in the field of Psychiatry and Mental Health, published by Wiley since its inception in 1926. With a strong commitment to advancing psychiatric research, this esteemed journal boasts an impressive impact factor and ranks within the top 7% of its category, reflecting its influence and relevance in the field. Operating without an Open Access model, the journal serves as a vital resource for professionals, researchers, and students keen on accessing high-quality, peer-reviewed studies focused on mental health issues. The scope of ACTA PSYCHIATRICA SCANDINAVICA spans a broad spectrum of psychiatric topics, providing a platform for groundbreaking research and clinical practice insights. Based in the United Kingdom and featuring contributions from experts worldwide, the journal continues to shape the future of psychiatric research through its rigorous publication standards and commitment to scholarly excellence.

EUROPEAN NEUROPSYCHOPHARMACOLOGY, published by Elsevier, is a prestigious academic journal that serves as a cornerstone in the field of neuropsychopharmacology, embracing multidisciplinary research at the intersection of neuroscience, psychiatry, and pharmacology. Since its establishment in 1990, this journal has consistently delivered cutting-edge research and reviews that drive forward our understanding of central nervous system disorders and their treatment. With an impressive impact factor and ranked in the Q1 category for several disciplines, including Biological Psychiatry and Neurology, it attracts submissions from leading researchers globally. The journal’s Scopus rankings reflect its significant influence, ranking in the top echelons across various categories such as Medicine and Neuroscience. While the journal maintains subscription access, readers are encouraged to explore the breadth of important findings that contribute to advancements in treatment options and improve patient care. EUROPEAN NEUROPSYCHOPHARMACOLOGY not only supports the dissemination of pivotal research but also fosters collaboration and dialogue within the scientific community, making it an essential resource for researchers, clinicians, and students dedicated to the complexities of brain health.